Study population characteristics | n = 42 |
---|---|
Age (years) | 65.9 ± 7.7 |
Male gender (%) | 76.2 |
BMI (kg/m2) | 27.8 ± 4.1 |
Clinical symptomatology (%) | 50.0 |
CAD (%) | 30.0 |
Smoking (%) | 71.4 |
Hypertension (%) | 83.3 |
Type II diabetes mellitus (%) | 31.0 |
β-Blockers (%) | 32.5 |
ACE inhibitors (%) | 37.5 |
CaCB (%) | 45.0 |
Diuretics (%) | 15.0 |
Clopidogrel (%) | 50.0 |
ASA (%) | 45.0 |
Antidiabetics (%) | 25.0 |
Insulin (%) | 5.0 |
Statins (%) | 38.1 |